BioHealth News
BioPharmaDive: Biotech landlord (and BHI Board Member) Joel Marcus on research clusters and the sector’s recovery
Joel Marcus, the longtime head of Alexandria Real Estate Equities, sees few near-term challengers to the established biotech hubs of Boston, San Diego and…
Read More
FDA establishes CDER Center for Clinical Trial Innovation (C3TI)
[4/15/2024] Today, FDA's Center for Drug Evaluation and Research (CDER) announced the launch of the CDER Center for Clinical Trial Innovation (C3TI). C3TI’s mission is to promote…
Read More
Pitchbook: 3 charts: The US has more startups than VCs can support
2024 may well become the year of the bootstrapped founder. The startup “mass extinction event” that doomsayers have predicted for two years is likely…
Read More
Adventist HealthCare Earns Spot on Newsweek’s Most Trustworthy Companies in America 2024 List
GAITHERSBURG, Md. – Adventist HealthCare has been named one of Newsweek’s Most Trustworthy Companies in America 2024. The list of 700 U.S. companies was announced…
Read More
STAT: NCI director expresses optimism about next era of cancer research, despite shrinking budget and brain drain
SAN DIEGO — Kimryn Rathmell, director of the National Cancer Institute, gestured toward the screen and asked an audience of clinicians, researchers, and patient…
Read More
WaPo: Former NIH director Collins on his prostate cancer, medical research
Over my 40 years as a physician-scientist, I’ve had the privilege of advising many patients facing serious medical diagnoses. I’ve seen them go through…
Read More
TEDCO Invests in Astek Diagnostics
Maryland biotech company continuing mission to provide antibiotic sensitivity precision diagnostics COLUMBIA, Md. (April 15, 2024) – fdfsTEDCO, Maryland’s economic engine for technology companies,…
Read More
TEDCO Announces Federal Lab Leveraging Innovation to Products Pilot Program
Senators Cardin and Van Hollen requested more than $1 million to fund this new program COLUMBIA, Md., (April 11, 2024) — TEDCO, Maryland’s economic engine…
Read More
TEDCO Invests in Aloe Therapeutics
COLUMBIA, Md. (April 8, 2024) – TEDCO, Maryland’s economic engine for technology companies, announced a recent $100,000 Pre-Seed Builder Fund investment in Aloe Therapeutics,…
Read More
Technical.ly: How Baltimore plans to spend $70M in EDA Tech Hubs Funding
Anticipation is building for the pending decision on Baltimore’s Phase 2 Tech Hubs application to the US Economic Development Administration (EDA). That energy was…
Read More
Medcura Closes $22.4 Million Financing to Accelerate Development of Surgical Hemostatic Gel and Surgical Hemostasis Portfolio
RIVERDALE, Md., April 3, 2024 /PRNewswire/ -- Medcura, Inc., a developer of hemostatic products for use in surgery, today announced that it has closed a private placement…
Read More
NeoImmuneTech Appoints Dr. Luke Oh, Ph.D. as New Chief Executive Officer
ROCKVILLE, Md., April 2, 2024 /PRNewswire/ -- NeoImmuneTech, Inc. (KOSDAQ: 950220), announced that Luke Oh, Ph.D. has been appointed as President and Chief Executive Officer (CEO)…
Read More
CF Foundation Provides Up to $8.5M to SpliSense to Support a Clinical Trial for a Potential Treatment for Splicing Mutations
BETHESDA, Md.--(BUSINESS WIRE)--The Cystic Fibrosis Foundation is investing up to $8.5 million in additional funds in SpliSense to continue clinical trials for its inhaled antisense…
Read More
Washington DC’s Vanda Pharmaceuticals’ Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder
WASHINGTON, April 2, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved Fanapt® (iloperidone) tablets for…
Read More
Washington D.C.’s 60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis
WASHINGTON, April 03, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (or the “Company”), a pharmaceutical company focused on developing new medicines for infectious…
Read More